Automatic Biochip Reader Market size was valued at US$ 234 million in 2024 and is projected to reach US$ 456 million by 2032, at a CAGR of 9.8% during the forecast period 2025-2032
Report Studies
• The global Automatic Biochip Reader Market size was valued at US$ 234 million in 2024 and is projected to reach US$ 456 million by 2032, at a CAGR of 9.8% during the forecast period 2025-2032.
• Automatic biochip readers are advanced analytical instruments designed to detect and analyze biological samples on biochips or microarrays. These devices utilize technologies such as CCD (charge-coupled device) systems or laser confocal scanning to measure fluorescence, luminescence, or other optical signals from biological assays. They play a critical role in applications like genomics, proteomics, drug discovery, and clinical diagnostics by enabling high-throughput screening and precise data acquisition.
help@semiconductorinsight.com
By Type:
• Laser Confocal Biochip Reader Segment Leads Due to High Precision in Imaging Applications
• The market is segmented based on type into:
• CCD System Biochip Reader
• Laser Confocal Biochip Reader
By Application:
• The market is segmented based on application into:
• Tumor Detection
• Drug Screening
• Personalized Medicine
• Applied Precision (U.S.)
• Beijing Novogene (China)
• Jiangsu Sunlant (China)
• Pilotgene (China)
• CapitalBio Corporation (China)
• Shenzhen Sciarray (China)
